A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy

Clinical trial NCT06866964 · RECRUITING

Trial details

NCT number: NCT06866964
Sponsor: Wake Forest University Health Sciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Germ Cell Tumor Testicular Cancer

Start date: 2025-08-28
Primary completion: 2029-08-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.